ETHNIC-DIFFERENCES IN DRUG DISPOSITION AND RESPONSIVENESS

被引:148
作者
WOOD, AJJ
ZHOU, HH
机构
[1] Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee
关键词
D O I
10.2165/00003088-199120050-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Interethnic differences are important factors accounting for interindividual variations in drug responsiveness. However, these differences in drug response have been a relatively neglected area of investigation, so that similar doses are prescribed to different ethnic populations without consideration of interethnic pharmacokinetic and pharmacodynamic variation. With the increased recognition of genetically determined polymorphism in metabolising ability as an important factor in drug disposition, concern has developed for the importance of individualising drug dose to account for racial differences. The recognition of these differences in drug disposition and responses calls into question the failure of drug licensing authorities to demand information on dosage, efficacy and toxicity in different ethnic groups, and to accept data from limited ethnic groups such as Caucasians. This article reviews the evidence for ethnic differences in drug disposition and sensitivity and should encourage further investigations to elucidate the extent of such differences, their causes and their therapeutic impact.
引用
收藏
页码:350 / 373
页数:24
相关论文
共 184 条
[1]  
ABSON CP, 1981, S AFR MED J, V60, P47
[2]   INTERINDIVIDUAL DIFFERENCES IN PLASMA-PROTEIN BINDING OF NORTRIPTYLINE IN MAN - TWIN STUDY [J].
ALEXANDERSON, B ;
BORGA, O .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 4 (04) :196-+
[3]  
ALLEN JJ, 1977, POSTGRAD MED J, V53, P79
[4]   FAMILY STUDY OF GENETIC AND ENVIRONMENTAL-FACTORS DETERMINING THE PROTEIN-BINDING OF PROPRANOLOL [J].
ALVAN, G ;
BERGSTROM, K ;
BORGA, O ;
ISELIUS, L ;
PEDERSEN, N .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (04) :437-441
[5]  
ALVAN G, 1982, LANCET, V1, P333
[6]   NO EVIDENCE FOR THE PRESENCE OF POOR METABOLIZERS OF SPARTEINE IN AN AMERINDIAN GROUP - THE CUNAS OF PANAMA [J].
ARIAS, TD ;
JORGE, LF ;
INABA, T .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (05) :547-548
[7]  
ARMSTRONG AR, 1960, AM REV RESPIR DIS, V81, P588
[8]   METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].
AYESH, R ;
IDLE, JR ;
RITCHIE, JC ;
CROTHERS, MJ ;
HETZEL, MR .
NATURE, 1984, 312 (5990) :169-170
[9]   DEBRISOQUIN OXIDATION POLYMORPHISM IN A SPANISH POPULATION [J].
BENITEZ, J ;
LLERENA, A ;
COBALEDA, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) :74-77
[10]   HALOPERIDOL DECANOATE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN PSYCHOSIS [J].
BERESFORD, R ;
WARD, A .
DRUGS, 1987, 33 (01) :31-49